Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation.

Abstract

KEY POINTS A trial fibrillation, the most common arrhythmia encountered in clinical practice, is a leading cause of morbidity and mortality[1][1] with an incidence that increases with age. Patients with atrial fibrillation, particularly older adults, have a substantially increased risk of